UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene ...

Boehringer Ingelheim is discarding an inhaled gene therapy designed to treat cystic fibrosis (CF) after terminating a phase 1 ...

Despite groundbreaking research, many cell and gene therapies do not make it all the way to the patients. Researchers and clinicians in Lund have now presented a new model for cooperation that will ...

Gene therapy is a medical treatment that works by changing or fixing a person's genes to treat or prevent disease ...

Creative Biolabs is accelerating gene therapy research globally with specialized expertise. SHIRLEY, NY, UNITED STATES, ...

As Eli Lilly awaits an FDA approval decision for its oral GLP-1 orforglipron, the pharma has discarded three clinical-stage ...

FDA RMAT boosts inhaled gene therapy KB707, delivering IL‑2/IL‑12 to lung tumors; early trial shows responses with manageable ...

Despite groundbreaking research, many cell and gene therapies do not make it all the way to the patients. Researchers and clinicians in Lund have now ...

再生医療の研究拠点「中之島クロス」（大阪市）を運営する未来医療推進機構は英国の政府系研究機関Cell and Gene Therapy Catapultと提携した 再生医療の研究拠点「中之島クロス」（大阪市）を運営する未来医療推進機構は16日、英国の政府系研究機関「Cell and Gene ...

A Phase 3 clinical trial testing SGT-003, a gene therapy candidate for Duchenne muscular dystrophy (DMD), will start dosing ...

This report provides an in-depth analysis of the Cell and Gene Therapy industry, highlighting key company revenues, ...

A patient in Oxford has been treated for a degenerative eye condition as part of a new clinical trial by the genetic ...